17 June, 2022 Central Drugs Standard Control Organization (CDSCO), the central drug regulatory agency of Government of India has issued a new draft gazette notification to notify Schedule H2 drugs and amendment in Rule 96 of Drugs and Cosmetics…
Recent Post
- India Imposes National Ban on Nimesulide for Veterinary Use Due to Toxicity Risks
- Major Relief for MSME Pharma Manufacturers: MoHFW Extends Deadline for Revised GMP Compliance
- Pharmacovigilance system compliance in India
- Simplifying Clinical Trial Amendment Approvals in India
- Navigating Drug Rules in India: A Guide for Pharmaceutical Marketers